Skip to Main Content
The first stop for professional medicines advice

Patient Group Directions

150 results

Applied filters

Iomeprol contrast agent

11 February 2026SPS PGD template for administering iomeprol intravenously for imaging investigations and procedures by registered Radiographers.

Implementing the SPS Patient Group Direction, Written Instruction and protocol templates

19 June 2025SPS national templates can be implemented by organisations to improve consistency and reduce duplication of effort.

Off label medicine use under a Patient Group Direction

2 June 2025This article explains the legislation and guidance on the use of PGDs when a medicine is to be used outside its licence ('off-label').

Patient Group Directions in Complex Commissioning Scenarios

8 April 2024This guide supports planning, decision making and advises on governance processes when PGDs are used within commissioned services.

Repeat supply or administration of medicines under PGD

17 October 2025Patient Group Directions are not an appropriate mechanism for regular repeated supplies or administration of a medicine. Prescribing is preferred.

Electronic record systems and Patient Group Directions

10 November 2025Advice on Patient Group Direction (PGD) management using electronic systems

Authorising Independent Healthcare Provider (IHP) PGDs

15 April 2024Considerations are needed when NHS or local authorities commission services using PGDs from independent healthcare providers.

UK Health Security Agency (UKHSA) PGD Templates

8 April 2024Patient Group Direction templates by UKHSA are developed for a range of clinical scenarios. A summary of the processes to use and further links are provided.

Abortifacients and Patient Group Directions (PGDs)

10 November 2025This article advises on the legal position on the supply/administration of abortifacients under PGDs.

Auditing Patient Group Directions

2 June 2025SPS have developed a template audit tool to support organisations in auditing aspects of PGD development and use.